SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-21-000269
Filing Date
2021-08-13
Accepted
2021-08-13 14:12:47
Documents
51
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q rgbp123120form10q.htm 10-Q 1294994
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9506
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 9485
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4231
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4102
  Complete submission text file 0001607062-21-000269.txt   4400805

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rgbp-20201231.xml EX-101.INS 649729
7 XBRL SCHEMA FILE rgbp-20201231.xsd EX-101.SCH 68883
8 XBRL CALCULATION FILE rgbp-20201231_cal.xml EX-101.CAL 39883
9 XBRL DEFINITION FILE rgbp-20201231_def.xml EX-101.DEF 200599
10 XBRL LABEL FILE rgbp-20201231_lab.xml EX-101.LAB 324296
11 XBRL PRESENTATION FILE rgbp-20201231_pre.xml EX-101.PRE 247977
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 211171395
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences